Identify the pathways driving disease and distinguish them from adaptive or compensatory biology.
BioGPU
Where AI Runs to Resolve Biology
Causal biology resolved across the discovery lifecycle
Understand the causal biology driving disease,
the function of targets,
and the effects of compounds.
Pathway
Resolution
Target
Resolution
Understand what targets do, how they are regulated, and how they influence disease biology.
Compound
Resolution
Explain what compounds do in biology, why they succeed or fail, and how resistance emerges.
The biology runtime for AI.
BioGPU enables AI models to reason inside cells through massive parallel visual biology experiments.
BioGPU Agent
BioGPU Runtime
Massive parallel visual biology experiments
Visual Biology Tokens
-
Protein
localization -
Nuclear
translocation -
Phospho-
signaling -
Cytoskeletal
dynamics -
Mitochondrial
state -
RNA
granules -
Protein
interactions
1000+
Experiments at each iteration
Cells
Millions of cells across diseases,
conditions and perturbations
conditions and perturbations
Visual Biology Tokens
FRONT: THE STATEMENT
Textual statement of biological activity
VB-0001
SOD1 is abnormally enriched in the nucleus.
VB-0002
P-TDP-43 accumulates strongly in both cytoplasm and nucleus.
VB-0003
4EBP1 is phosphorylated across both nuclear and cytoplasmic compartments despite unchanged levels.
VB-0004
SRSF2 is strongly upregulated in the nucleus.
front
VISUAL BIOLOGY TOKENS
THOUSANDS OF TOKENS
produced per experiment
Across pathways, cell types, conditions and diseases
back
BACK: THE EVIDENCE
Dynamic visual evidence (Healthy vs Disease)
SOD1
H
D
P-TDP-43
H
D
4EBP1 (p)
H
D
SRSF2
H
D
BioGPU Agent
Chat with cells.
Experimentally resolving the biology of
pathways, targets, and compounds.
BioGPU Runtime
Massive parallel visual biology experiments
BioGPU Agent - Driving the BioGPU runtime
BioGPU agent executes on the BioGPU runtime to resolve causal biology in ALS and discover novel targets